SBIR: Translate Academic Arthritis, Musculoskeletal, and Skin Research to Market (R43/R44, No Clinical Trials)
This SBIR opportunity funds small businesses to commercialize late-stage biomedical or behavioral research results in arthritis, musculoskeletal, and skin diseases that originate in academic or nonprofit labs. Projects should advance validated discoveries toward market-ready products or services; clinical trials are not allowed under this program.
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Funding Source
Awards & funding
Eligibility
Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.<…
Supporting links
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers